Paragon 28
-
Extremities
Paragon 28 Launches PRECISION® MIS Bunion System Offering Surgeons a Guided Minimally Invasive Surgical Solution for Treating Patients with Bunions
ENGLEWOOD, Colo., February 1, 2024 –(BUSINESS WIRE)– Paragon 28, Inc. (NYSE: FNA) is pleased to announce the launch of the…
Read More » -
Extremities
Paragon 28 Announces the Launch of the FJ2000™ Power Console and Burr System Designed Specifically for Foot and Ankle Procedures
ENGLEWOOD, Colo., January 24, 2024 –(BUSINESS WIRE)– Paragon 28, Inc. (NYSE: FNA) is proud to announce a novel solution in…
Read More » -
Extremities
Paragon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic™ – A Next Generation Clamp and Cut Guide System for Lapidus Bunion Procedures
ENGLEWOOD, Colo., January 17, 2024–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA), is excited to announce the limited market release of its…
Read More » -
Financial
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023
ENGLEWOOD, Colo., January 8, 2024–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “P28”), a leading medical device company exclusively…
Read More » -
Extremities
Paragon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler® Knotless Anchor System and Innovative Bridgeline™ Tape
ENGLEWOOD, Co., January 5, 2024 –(BUSINESS WIRE)– Paragon 28, Inc. (NYSE: FNA), is thrilled to announce the launch of the…
Read More » -
Financial
Paragon 28 Announces New $150 Million Credit Facility Replacing Existing $90 Million Credit Facility
ENGLEWOOD, Colo., November 7, 2023–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively…
Read More » -
Financial
Paragon 28 Reports Third Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
ENGLEWOOD, Colo., November 7, 2023–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively…
Read More » -
Financial
Paragon 28 Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
ENGLEWOOD, Colo., August 2, 2023–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively…
Read More » -
Extremities
Paragon 28 Launches Comprehensive Supramalleolar Osteotomy System
Gorilla® SMO Anterior Dome, Medial Closing Wedge, and Medial Opening Wedge Plating Configurations ENGLEWOOD, Colo., May 23, 2023–(BUSINESS WIRE)–Paragon 28,…
Read More » -
Financial
Paragon 28 Reports First Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance
ENGLEWOOD, Colo., May 5, 2023–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively…
Read More »